11 Rao Y, Haucke V. Membrane shaping by the bin/amphiphysin/rvs (bar) domain protein superfamily. Cell Mol Life Sci, 2011, 68: 3983-3993
[2]
12 Dawson J C, Legg J A, Machesky L M. Bar domain proteins: A role in tubulation, scission and actin assembly in clathrin-mediated endocytosis. Trends Cell Biol, 2006, 16: 493-498
[3]
13 Kabaso D, Gongadze E, Jorgacevski J, et al. Exploring the binding dynamics of bar proteins. Cell Mol Biol Lett, 2011, 16: 398-411
[4]
14 Chen Y, Aardema J, Misra A, et al. Bar proteins in cancer and blood disorders. Int J Biochem Mol Biol, 2012, 3: 198-208
[5]
22 Zhang F, Fan H. Mtss1: A metastasis suppressor candidate (in Chinese)? J Southeast Univ (Med Sci Ed), 2009, 28: 239-243 [张凤, 樊红. Mtss1——候选的肿瘤转移抑制基因? 东南大学学报(医学版), 2009, 28: 239-
[6]
23 Bompard G, Sharp S J, Freiss G, et al. Involvement of rac in actin cytoskeleton rearrangements induced by MIM-B. J Cell Sci, 2005, 118: 5393-5403
[7]
24 Suetsugu S, Murayama K, Sakamoto A, et al. The rac binding domain/irsp53-mim homology domain of irsp53 induces rac-dependent membrane deformation. J Biol Chem, 2006, 281: 35347-35358
[8]
25 Dawson J C, Bruche S, Spence H J, et al. Mtss1 promotes cell-cell junction assembly and stability through the small gtpase rac1. PLoS One, 2012, 7: e31141
[9]
26 Zhong L L, Shi N, Liang S P, et al. Identification of proteins interacting with the homology domain of IRSp53 and MIM (in Chinese). Acta Laser Biol Sin, 2009, 18: 359-364 [钟娈娈, 石妮, 梁宋平, 等. IRSP53和MIM同源结构域imd相互作用蛋白质的鉴定. 激光生物学报, 2009, 18: 359-
[10]
27 Woodings J A, Sharp S J, Machesky L M. Mim-b, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta. Biochem J, 2003, 371: 463-471
[11]
28 Lin J X, Liu J L, Wang Y, et al. Differential regulation of cortactin and n-wasp-mediated actin polymerization by missing in metastasis (mim) protein. Oncogene, 2005, 24: 2059-2066
[12]
29 Mattila P K, Salminen M, Yamashiro T, et al. Mouse MIM, a tissue-specific regulator of cytoskeletal dynamics, interacts with atp-actin monomers through its c-terminal wh2 domain. J Biol Chem, 2003, 278: 8452-8459
[13]
30 Liu W, Komiya Y, Mezzacappa C, et al. Mim regulates vertebrate neural tube closure. Development, 2011, 138: 2035-2047
[14]
31 Uruno T, Liu J L, Zhang P J, et al. Activation of arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol, 2001, 3: 259-266
[15]
32 Gonzalez-Quevedo R, Shoffer M, Horng L, et al. Receptor tyrosine phosphatase-dependent cytoskeletal remodeling by the hedgehog- responsive gene mim/beg4. J Cell Biol, 2005, 168: 453-463
[16]
33 Lee S H, Kerff F, Chereau D, et al. Structural basis for the actin-binding function of missing-in-metastasis. Structure, 2007, 15: 145-155
[17]
34 Ulbrich C, Pietsch J, Grosse J, et al. Differential gene regulation under altered gravity conditions in follicular thyroid cancer cells: Relationship between the extracellular matrix and the cytoskeleton. Cell Physiol Biochem, 2011, 28: 185-198
[18]
35 Wang Y, Zhou K, Zeng X C, et al. Tyrosine phosphorylation of missing in metastasis protein in implicated in platelet-derived growth factor-mediated cell shape changes. J Biol Chem, 2007, 282: 7624-7631
[19]
36 Callahan C A, Ofstad T, Horng L, et al. Mim/beg4, a sonic hedgehog-responsive gene that potentiates Gli-dependent transcription. Genes Dev, 2004, 18: 2724-2729
[20]
37 Bershteyn M, Atwood S X, Woo W M, et al. Mim and cortactin antagonism regulates ciliogenesis and hedgehog signaling. Dev Cell, 2010, 19: 270-283
[21]
38 Atwood S X, Li M, Lee A, et al. Gli activation by atypical protein kinase c em/l regulates the growth of basal cell carcinomas. Nature, 2013, 494: 484-488
[22]
39 Yu D, Zhan X H, Zhao X F, et al. Mice deficient in mim expression are predisposed to lymphomagenesis. Oncogene, 2012, 31: 3561-3568
[23]
40 Mattila P K, Pykalainen A, Saarikangas J, et al. Missing-in-metastasis and irsp53 deform pi(4,5)p2-rich membranes by an inverse bar domain-like mechanism. J Cell Biol, 2007, 176: 953-964
[24]
41 Zimmerberg J, McLaughlin S. Membrane curvature: How bar domains bend bilayers. Curr Biol, 2004, 14: R250-R252
[25]
1 Frost A, Unger V M, De Camilli P. The bar domain superfamily: Membrane-molding macromolecules. Cell, 2009, 137: 191-196
[26]
2 Ren G, Vajjhala P, Lee J S, et al. The bar domain proteins: Molding membranes in fission, fusion, and phagy. Microbiol Mol Biol Rev, 2006, 70: 37-120
[27]
4 Liu P S, Rudick M, Anderson R G W. Multiple functions of caveolin-1. J Biol Chem, 2002, 277: 41295-41298
[28]
5 Praefcke G J K, McMahon H T. The dynamin superfamily: Universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol, 2004, 5: 133-147
[29]
6 Peter B J, Kent H M, Mills I G, et al. Bar domains as sensors of membrane curvature: The amphiphysin bar structure. Science, 2004, 303: 495-499
[30]
7 Itoh T, De Camilli P. Bar, f-bar (efc) and enth/anth domains in the regulation of membrane-cytosol interfaces and membrane curvature. Biochim Biophys Acta, 2006, 1761: 897-912
[31]
8 Pykalainen A, Boczkowska M, Zhao H X, et al. Pinkbar is an epithelial-specific bar domain protein that generates planar membrane structures. Nat Struct Mol Biol, 2011, 18: 902-959
[32]
9 Suetsugu S, Toyooka K, Senju Y. Subcellular membrane curvature mediated by the bar domain superfamily proteins. Semin Cell Dev Biol, 2010, 21: 340-349
[33]
10 McMahon H T, Gallop J L. Membrane curvature and mechanisms of dynamic cell membrane remodelling. Nature, 2005, 438: 590-596
[34]
42 Futo K, Bodis E, Machesky L M, et al. Membrane binding properties of irsp53-missing in metastasis domain (imd) protein. Biochim Biophys Acta, 2013, 1831: 1651-1655
[35]
43 Saarikangas J, Zhao H, Pykalainen A, et al. Molecular mechanisms of membrane deformation by i-bar domain proteins. Curr Biol, 2009, 19: 95-107
[36]
44 Kabaso D, Bobrovska N, Gozdz W, et al. On the role of membrane anisotropy and bar proteins in the stability of tubular membrane structures. J Biomech, 2012, 45: 231-238
[37]
45 Blood P D, Voth G A. Direct observation of bin/amphiphysin/rvs (bar) domain-induced membrane curvature by means of molecular dynamics simulations. Proc Natl Acad Sci USA, 2006, 103: 15068-15072
[38]
46 Simunovic M, Mim C, Marlovits T C, et al. Protein-mediated transformation of lipid vesicles into tubular networks. Biophys J, 2013, 105: 711-719
[39]
47 Cui H S, Mim C, Vazquez F X, et al. Understanding the role of amphipathic helices in n-bar domain driven membrane remodeling. Biophys J, 2013, 104: 404-411
[40]
48 Hsin J, Gopinathan A, Huang K C. Nucleotide-dependent conformations of ftsz dimers and force generation observed through molecular dynamics simulations. Proc Natl Acad Sci USA, 2012, 109: 9432-9437
[41]
49 Barducci A, Bonomi M, Prakash M K, et al. Free-energy landscape of protein oligomerization from atomistic simulations. Proc Natl Acad Sci USA, 2013, 110: E4708-4713
[42]
50 Vivcharuk V, Tomberli B, Tolokh I S, et al. Prediction of binding free energy for adsorption of antimicrobial peptide lactoferricin b on a popc membrane. Phys Rev E Stat Nonlin Soft Matter Phys, 2008, 77: 031913
[43]
51 Nawae W, Hannongbua S, Ruengjitchatchawalya M. Defining the membrane disruption mechanism of kalata b1 via coarse-grained molecular dynamics simulations. Sci Reports, 2014, 4: 3933
[44]
52 Huggins D J, McKenzie G J, Robinson D D, et al. Computational analysis of phosphopeptide binding to the polo-box domain of the mitotic kinase plk1 using molecular dynamics simulation. PLoS Comput Biol, 2010, 6: e1000880
[45]
63 Whitmarsh A J, Davis R J. Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene, 2007, 26: 3172-3184
[46]
64 Hurst D R. Metastasis suppression by brms1 associated with sin3 chromatin remodeling complexes. Cancer Metastasis Rev, 2012, 31: 641-651
[47]
65 Chen X P, Xu Z T, Wang Y T. Recent advances in breast cancer metastasis suppressor 1. Int J Biol Markers, 2011, 26: 1-8
[48]
66 Wang Y, Liu J, Smith E, et al. Downregulation of missing in metastasis gene (MIM) is associated with the progression of bladder transitional carcinomas. Cancer Invest, 2007, 25: 79-86
[49]
67 Guo Y, Zhang H, Hong Y, et al. The expression of MTSS1 gene in bladder carcinoma and its influence to proliferation and apoptosis in bladder carcinoma cells (in Chinese). Prog Anatom Sci, 2012, 18: 116-118 [郭艳, 张辉, 洪杨, 等. MTSS1基因在膀胱癌组织中的表达及对膀胱癌细胞增殖和凋亡的影响. 解剖科学进展, 2012, 18: 116-
[50]
68 Lam D C L, Girard L, Suen W S, et al. Establishment and expression profiling of new lung cancer cell lines from chinese smokers and lifetime never-smokers. J Thorac Oncol, 2006, 1: 932-942
[51]
69 Nymark P, Guled M, Borze I, et al. Integrative analysis of microrna, mrna and acgh data reveals asbestos- and histology-related changes in lung cancer. Genes Chromosomes Cancer, 2011, 50: 585-597
[52]
70 Zhao W, Han H B, Zhang Z Q. Suppression of lung cancer cell invasion and metastasis by connexin43 involves the secretion of follistatin-like1 mediated via histone acetylation. Int J Biochem Cell Biol, 2011, 43: 1459-1468
[53]
71 Fang W Z, Hong J F, Wu D S, et al. Expression of MTSS1 and its clinicopathological significance in non-small cell lung cancer (in Chinese). Chin Clin Oncol, 2014, 19: 199-203 [房文铮, 洪峻峰, 吴淡森, 等. MTSS1在非小细胞肺癌中的表达及临床意义. 临床肿瘤学杂志, 2014, 19: 199-
[54]
72 Parr C, Jiang W G. Metastasis suppressor1 (mtss1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur J Cancer, 2009, 45: 1673-1683
[55]
73 Zhong J T, Shaik S, Wan L X, et al. Scf beta-trcp targets mtss1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration. Oncotarget, 2013, 4: 2339-2353
[56]
75 Chen Y G, Liu K, Zhu R, et al. Expression of MIM and VEGF and their prognosticsignificance in gastric carcinoma (in Chinese). China J Modern Med, 2011, 17: 1615-1619 [陈义钢, 柳珂, 朱荣, 等. MIM与VEGF在胃癌中的表达及其预后意义的研究. 中国现代医学杂志, 2011, 17: 1615-
[57]
76 Fan L H, Liu K, Yu G Z, et al. Loss of heterozygosity and abnormal expression of MTSS1 in the progression and metastasis of advanced primary gastric carcinoma (in Chinese). Tumor, 2011, 31: 255-260 [范理宏, 柳珂, 于观贞, 等. MTSS1基因表达异常及杂合性缺失在晚期胃癌发展及转移中的作用. 肿瘤, 2011, 31: 255-
[58]
77 Xie F, Ye L, Chen J F, et al. The impact of metastasis suppressor-1, mtss1, on oesophageal squamous cell carcinoma and its clinical significance. J Transl Med, 2011, 9: 95
[59]
95 Hirata H, Ueno K, Shahryari V, et al. Microrna-182-5p promotes cell invasion and proliferation by down regulating foxf2, reck and mtss1 genes in human prostate cancer. PLoS One, 2013, 8: e55502
[60]
96 Lei R, Tang J, Zhuang X, et al. Suppression of mim by microrna-182 activates rhoa and promotes breast cancer metastasis. Oncogene, 2014, 33: 1287-1296
[61]
97 Wang J, Li J W, Shen J L, et al. Microrna-182 downregulates metastasis suppressor1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer, 2012, 12: 227
[62]
98 Nixdorf S, Grimm M O, Loberg R, et al. Expression and regulation of mim (missing in metastasis), a novel putative metastasis suppressor gene, and mim-b, in bladder cancer cell lines. Cancer Lett, 2004, 215: 209-220
[63]
99 Wang D, Xu M R, Wang T, et al. Mtss1 overexpression correlates with poor prognosis in colorectal cancer. J Gastrointest Surg, 2011, 15: 1205-1212
[64]
100 Wang D, Xu M R, Zhu J W. Expression and significance of Mtss1 in benign and malignant colon tissue (in Chinese). Chin J Clin (Electron Ed), 2010, 4: 2534-2537 [王鼎, 徐美荣, 朱建伟. Mtss1在大肠良恶性组织中的表达及其意义. 中华临床医师杂志(电子版), 2010, 4: 2534-
[65]
101 Zheng B, Li S Y, An P, et al. Expression of metastasis suppressor1 in colorectal cancer (in Chinese). Chin J Operat Proc Gen Surg (Electron Ed), 2013, 7: 230-232 [郑斌, 李世拥, 安萍, 等. 肿瘤转移抑制蛋白1在结直肠癌组织中的表达及意义研究进展. 中华普外科手术学杂志(电子版), 2013, 7: 230-
[66]
102 Hu D, Zhang H J, Lin X D, et al. Expression of mRNAs missing in metastasis in primary breast carcinoma and its clinical signifi cancer (in Chinese). Int J Pathol Clin Med, 2012, 32: 12-16 [胡丹, 张和军, 林贤东, 等. 转移消失基因在乳腺癌中的表达及其临床意义. 国际病理科学与临床杂志, 2012, 32: 12-
[67]
103 Folgueira M A, Carraro D M, Brentani H, et al. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res, 2005, 11: 7434-7443
[68]
104 Sobral R A, Honda S T, Katayama M L H, et al. Tumor slices as a model to evaluate doxorubicin in vitro treatment and expression of trios of genes prss11, mtss1, clptm1 and prss11, mtss1, smyd2 in canine mammary gland cancer. Acta Veterin Scandinav, 2008, 50: 27
[69]
105 Mertz K D, Pathria G, Wagner C, et al. Mtss1 is a metastasis driver in a subset of human melanomas. Nat Commun 2014, 5: 3465
[70]
106 Ji W, Bian Z H, Yu Y, et al. Expulsion of micronuclei containing amplified genes contributes to a decrease in double minute chromosomes from malignant tumor cells. Int J Cancer, 2014, 134: 1279-1288
[71]
107 Chen Q, Chen L, Zhao R, et al. Microarray analyses reveal liver metastasis-related genes in metastatic colorectal cancer cell model. J Cancer Res Clin Oncol, 2013, 139: 1169-1178
[72]
115 Shi N, Tian C, Liang X, et al. Proteome analysis of actin filament-associated proteins in the postnatal rat cerebellum. Neuroscience, 2012, 227: 90-101
[73]
116 Li Q L, Jimenez-Krassel F, Ireland J J, et al. Gene expression profiling of bovine preovulatory follicles: Gonadotropin surge and prostanoid-dependent up-regulation of genes potentially linked to the ovulatory process. Reproduction, 2009, 137: 297-307
[74]
120 Mao Y J, Jiang P, Liang S P, et al. Construction and identification of lentiviral RNA interference vector of mouse msl gene (in Chinese). Acta Laser Biol Sn, 2011, 20: 373-377 [毛亚江, 蒋鹏, 梁宋平, 等. 肿瘤转移抑制蛋白MTSS1 shRNA慢病毒载体的构建与鉴定. 激光生物学报, 2011, 20: 373-
[75]
3 McMahon H T, Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol, 2011, 12: 517-533
[76]
15 Millard T H, Bompard G, Heung M Y, et al. Structural basis of filopodia formation induced by the irsp53/mim homology domain of human irsp53. EMBO J, 2005, 24: 240-250
[77]
16 Machesky L M, Johnston S A. Mim: A multifunctional scaffold protein. J Mol Med, 2007, 85: 569-576
[78]
17 Xie F, Ye L, Ta M, et al. Mtss1: A multifunctional protein and its role in cancer invasion and metastasis. Front Biosci (Schol Ed), 2011, 3: 621-631
[79]
18 Chen Y G, Ding H Z. Updated correlation of homologous variants MIM and MIM-B with tumor metastasis (in Chinese). J Med Postgraduates, 2010, 23: 206-209 [陈义刚, 丁厚中. MIM及其同源异构体MIM-B基因与肿瘤转移之间关系的研究进展. 医学研究生学报, 2010, 23: 206-
[80]
19 Huang X Y, Huang Z L, Tang Z Y, et al. Role of proteins of missing in metastasis in cancer initiation and progression (in Chinese). Tumor, 2010, 30: 170-172 [黄修燕, 黄自丽, 汤钊猷, 等. 转移消失蛋白在肿瘤发生发展中的作用. 肿瘤, 2010, 30: 170-
[81]
20 Zhang J, Tong Y. Research progresses in correlation of MTSS1 gene and malignancy (in Chinese). J Practic Med, 2013, 29: 3084- 3086 [张娟, 童英. MTSS1与恶性肿瘤相关性研究进展. 实用医学杂志, 2013, 29: 3084-
[82]
21 Luo X Z, Hong Y M. Progress of candidate metastasis-suppressor gene (mtss1) and tumor (in Chinese). J Otolaryngol Ophthalmol Shandong Univ, 2014, 28: 79-83 [罗小邹, 洪育明. 候选转移抑制基因(mtss1)与肿瘤关系的研究进展. 山东大学耳鼻喉眼学报, 2014, 28: 79-
[83]
53 Koivuniemi A, Vuorela T, Kovanen P T, et al. Lipid exchange mechanism of the cholesteryl ester transfer protein clarified by atomistic and coarse-grained simulations. PLoS Comput Biol, 2012, 8: e1002299
[84]
54 Utikal J, Gratchev A, Muller-Molinet I, et al. The expression of metastasis suppressor mim/mtss1 is regulated by DNA methylation. Int J Cancer, 2006, 119: 2287-2293
[85]
55 Lee Y G, Macoska J A, Korenchuk S, et al. MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia, 2002, 4: 291-294
[86]
56 Smith R A, Manassaram-Baptiste D, Brooks D, et al. Cancer screening in the united states, a review of current american cancer society guidelines and current issues in cancer screening. Ca Cancer J Clin, 2014, 64: 31-51
[87]
57 Marino N, Nakayama J, Collins J W, et al. Insights into the biology and prevention of tumor metastasis provided by the nm23 metastasis suppressor gene. Cancer Metastasis Rev, 2012, 31: 593-603
[88]
58 Mehlen P, Puisieux A. Metastasis: A question of life or death. Nat Rev Cancer, 2006, 6: 449-458
[89]
59 Duman-Scheel M. Deleted in colorectal cancer (dcc) pathfinding: Axon guidance gene finally turned tumor suppressor. Curr Drug Targets, 2012, 13: 1445-1453
[90]
60 Maitra A, Hruban R H. Pancreatic cancer. Ann Rev Pathol Mechanisms Disease, 2008, 3: 157-188
[91]
61 Muller P A J, Vousden K H, Norman J C. P53 and its mutants in tumor cell migration and invasion. J Cell Biol, 2011, 192: 209-218
[92]
62 Liu W M, Zhang X A. Kai1/cd82, a tumor metastasis suppressor. Cancer Lett, 2006, 240: 183-194
[93]
74 Liu K, Wang G F, Ding H Z, et al. Downregulation of metastasis suppressor1 (mtss1) is associated with nodal metastasis and poor outcome in chinese patients with gastric cancer. BMC Cancer, 2010, 10: 428
[94]
78 Zhang S G, Guo X F, Lu Y, et al. MTSS1 expression in esophageal squamous cell carcinoma tissues and the correlation with cell migration and invasion in vitro (in Chinese). Chin J Cancer Prevent Treat, 2013, 17: 749-752 [张曙光, 郭晓锋, 路遥, 等. 食管鳞癌组织MTSS1表达及其与转移潜能相关性研究. 中华肿瘤防治杂志, 2013, 17: 749-
[95]
79 Fan H, Chen L, Zhang F, et al. MTSS1, a novel target of DNA methyltransferase 3b, functions as a tumor suppressor in hepatocellular carcinoma. Oncogene, 2012, 31: 2298-2308
[96]
80 Wang F, Liu Y L, Zhang H. Loss of mtss1 expression is an independent prognostic factor for hilar cholangiocarcinoma. Pathol Oncol Res, 2013, 19: 815-820
[97]
81 Xu L, Wang Z, Li X F, et al. Screening and identification of significant genes related to tumor metastasis and psma in prostate cancer using microarray analysis. Oncol Rep, 2013, 30: 1920-1928
[98]
82 Mustafa N, Martin T A, Jiang W G. Metastasis tumour suppressor-1 and the aggressiveness of prostate cancer cells. Exp Therap Med, 2011, 2: 157-162
[99]
83 Yu G Z, Chen Y, Chen F G, et al. Heterogeneity between primary colorectal carcinoma and matched metastases as revealed analysis of cDNA microarray (in Chinese). Chin Clin Oncol, 2008, 13: 715-720 [于观贞, 陈颖, 陈方国, 等. 结直肠癌原发瘤细胞和淋巴结转移瘤细胞基因表型差异的研究. 临床肿瘤学杂志, 2008, 13: 715-
[100]
84 Wang G F, Yu G Z, Wang Y M, et al. Expression of Mtss1 and its clinical pathological significance in co lorectal cance (in Chinese). Chin Clin Oncol, 2011, 16: 39-41 [王革芳, 于观贞, 王咏梅, 等. 转移抑制基因Mtss1在结肠癌组织中的表达及其意义. 临床肿瘤学杂志, 2011, 16: 39-
[101]
85 Ma L F, Jiang T, Wu X P, et al. Expression and clinical significance of MTSS1 and Hpa in colon cancer (in Chinese). Chin J Gastroenterol Hepatol, 2012, 21: 1014-1016 [马丽芳, 姜涛, 吴秀萍, 等. MTSS1和Hpa在结肠癌中的表达及其临床意义. 胃肠病学和肝病学杂志, 2012, 21: 1014-
[102]
86 Wang W Z, Ding H Z, Shi E Y, et al. Expression of MTSS1, Ezrin and Annexin II in colorectal carcinoma and their clinical significances (in Chinese). J Jiangsu Univ (Med Ed), 2012, 22: 265-274 [王万之, 丁厚中, 史恩溢, 等. MTSS1, Ezrin及Annexin Ⅱ在结直肠癌中的表达及其临床意义. 江苏大学学报(医学版), 2012, 22: 265-
[103]
87 Zheng B, Li S Y, An P, et al. Expression of MTSS1 in colorectal cancer and its clinical significance (in Chinese). Chin J Operat Proc Gen Surg (Electron Ed), 2014, 8: 44-47 [郑斌, 李世拥, 安萍, 等. MTSS1蛋白在结直肠癌组织中的表达及临床意义. 中华普外科手术学杂志(电子版), 2014, 8: 44-
[104]
88 Lu J, Getz G, Miska E A, et al. Microrna expression profiles classify human cancers. Nature, 2005, 435: 834-838
[105]
89 Jahid S, Sun J, Edwards R A, et al. Mir-23a promotes the transition from indolent to invasive colorectal cancer. Cancer Discov, 2012, 2: 540-553
[106]
90 Wang Z W, Wei W Y, Sarkar F H. Mir-23a, a critical regulator of “migr” ation and metastasis in colorectal cancer. Cancer Discov, 2012, 2: 489-491
[107]
91 Wang Y D, Zhang P N, Wang Z Q, et al. Expression and clinical significance of miR-23a and metastasis suppressor1 from tissue of gastric adenocarcinoma (in Chinese). J Radioimmunol, 2013, 25: 785-787 [王燕东, 张品南, 王忠泉, 等. 胃腺癌组织中mir-23a与转移抑制因子1的表达及意义. 放射免疫学杂志, 2013, 25: 785-
[108]
92 Liu S P, Guo W X, Shi J, et al. Microrna-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol, 2012, 56: 389-396
[109]
93 Zhou W W, Li X Y, Liu F, et al. Mir-135a promotes growth and invasion of colorectal cancer via metastasis suppressor1 in vitro. Acta Biochim Biophys Sin, 2012, 44: 838-846
[110]
94 Wu W Y, Wang Z, Yang P C, et al. Microrna-135b regulates metastasis suppressor1 expression and promotes migration and invasion in colorectal cancer. Mol Cell Biochem, 2014, 388: 249-259
[111]
108 Ma S, Guan X Y, Lee T K, et al. Clinicopathological significance of missing in metastasis b expression in hepatocellular carcinoma. Hum Pathol, 2007, 38: 1201-1206
[112]
109 Dawson J C, Timpson P, Kalna G, et al. Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells. Oncogene, 2012, 31: 1781-1793
[113]
110 Glassmann A, Molly S, Surchev L, et al. Developmental expression and differentiation-related neuron-specific splicing of metastasis suppressor i (mtss i) in normal and transformed cerebellar cells. BMC Dev Biol 2007, 7: 111
[114]
111 Holst M I, Maercker C, Pintea B, et al. Engrailed-2 regulates genes related to vesicle formation and transport in cerebellar purkinje cells. Mol Cell Neurosci, 2008, 38: 495-504
[115]
112 Hayn-Leichsenring G, Liebig C, Miething A, et al. Cellular distribution of metastasis suppressor1 and the shape of cell bodies are temporarily altered in engrailed-2 overexpressing cerebellar purkinje cells. Neuroscience, 2011, 189: 68-78
[116]
113 Shi N, Mao Y J, Zhang J J, et al. Antibody preparation and tyrosine phosphorylation level of Mtss1 in the different isoforms of rat cerebellum (in Chinese). Life Sci Res, 2010, 13: 1-5 [石妮, 毛亚江, 张敬敬, 等. Mtss1抗体制备及小脑中不同亚型磷酸化水平的检测. 生命科学研究, 2010, 13: 1-
[117]
114 Zhao H Y, Jin G H, Wang H Q, et al. The change of MTSS1 expression in the deafferented rat hippocampus (in Chinese). Chin J Neuroanatomy, 2013, 29: 405-409 [赵荷艳, 金国华, 王海琴, 等. 去神经支配大鼠海马内MTSS1的表达变化. 神经解剖学杂志, 2013, 29: 405-
[118]
117 Saarikangas J, Mattila P K, Varjosalo M, et al. Missing-in-metastasis mim/mtss1 promotes actin assembly at intercellular junctions and is required for integrity of kidney epithelia. J Cell Sci, 2011, 124: 1245-1255
[119]
118 He R J, Yu Z H, Zhang R Y, et al. Protein tyrosine phosphatases as potential therapeutic targets. Acta Pharmacol Sin, 2014, 35: 1227-1246
[120]
119 Cao M, Zhan T L, Ji M, et al. Dimerization is necessary for mim-mediated membrane deformation and endocytosis. Biochem J, 2012, 446: 469-475
